Leerink Partners Maintains Outperform on Incyte, Raises Price Target to $155

Benzinga Newsdesk www.benzinga.com Positive 92.1%

Neg 0% Neu 0% Pos 92.1%

Leerink Partners analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Outperform and raises the price target from $131 to $155.